Profile data is unavailable for this security.
About the company
AVE Science & Technology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of automatic inspection instruments and their matching reagents and consumables. The Company's product line covers automated testing instruments and matching reagents and consumables for samples such as urine, feces, reproductive tract secretions, blood and body fluids. The Company has also launched eight series of point-of-care testing (POCT) products, including those for women's health, scientific pregnancy, children's diarrhea, early screening for tumors, gastrointestinal diseases, urinary system diseases diabetes, and health physical fitness tests, covering the three major testing needs of daily physical examinations, early screening for diseases, and chronic disease monitoring.
- Revenue in CNY (TTM)221.12m
- Net income in CNY26.95m
- Incorporated2000
- Employees503.00
- LocationAVE Science & Technology Co LtdAVE Medical Technology Park, No. 26Fuling Road, Xueshi Neighborhood, YueluCHANGSHA 410208ChinaCHN
- Phone+86 73 189715453
- Fax+86 73 188907046
- Websitehttp://www.c-ave.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Rightongene Biotechnlgy Co Ltd | 191.78m | -27.11m | 1.74bn | 401.00 | -- | 1.92 | -- | 9.06 | -0.4824 | -0.4824 | 3.42 | 16.18 | 0.1954 | 1.29 | 1.14 | 478,253.60 | -4.05 | 2.48 | -4.25 | 2.67 | 70.61 | 69.35 | -20.73 | 7.60 | 13.93 | -- | 0.0028 | 16.94 | -6.16 | -1.05 | -298.78 | -- | -6.04 | -- |
| Jiangsu Nanfang Medical Co Ltd | 594.86m | -202.28m | 1.93bn | 850.00 | -- | 7.59 | -- | 3.25 | -0.6998 | -0.6998 | 2.06 | 0.88 | 0.5305 | 2.60 | 4.50 | 699,834.10 | -18.06 | -4.62 | -51.29 | -9.50 | -5.00 | 15.52 | -34.03 | -8.29 | 0.2557 | -6.48 | 0.6396 | -- | 0.4199 | 4.15 | -29.34 | -- | -10.48 | -- |
| AVE Science & Technology Co Ltd | 221.12m | 26.95m | 1.93bn | 503.00 | 71.66 | 3.73 | -- | 8.73 | 0.3963 | 0.3963 | 3.25 | 7.62 | 0.3796 | 2.09 | 40.74 | 439,603.90 | 4.63 | 5.20 | 5.19 | 5.87 | 55.98 | 57.49 | 12.19 | 12.48 | 4.47 | -- | 0.0547 | 32.92 | 1.50 | 1.37 | 6.07 | -14.68 | -31.29 | -- |
| Suzhou Iron Technology Co Ltd | 381.50m | 5.23m | 2.11bn | 680.00 | 346.59 | 2.72 | -- | 5.54 | 0.079 | 0.079 | 5.10 | 10.06 | 0.2822 | 2.23 | 1.50 | -- | 0.4366 | 4.75 | 0.7154 | 7.34 | 43.10 | 53.91 | 1.55 | 14.71 | 1.20 | 1.29 | 0.2133 | 31.78 | -10.52 | 2.22 | -173.52 | -- | -- | -- |
| Shanghai Rendu Biotechnology Co Ltd | 165.86m | -5.47m | 2.14bn | 335.00 | -- | 2.33 | -- | 12.92 | -0.1374 | -0.1374 | 4.14 | 22.92 | 0.1662 | 1.62 | 2.93 | 495,112.60 | -0.5482 | 4.37 | -0.5875 | 4.91 | 76.46 | 73.71 | -3.30 | 12.61 | 13.50 | -- | 0.0047 | 11.16 | 7.87 | 12.33 | -194.59 | -- | -28.11 | -- |
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 371.03m | -19.11m | 2.59bn | 796.00 | -- | 2.11 | -- | 6.98 | -0.2042 | -0.2042 | 3.97 | 13.10 | 0.2761 | 1.55 | 1.71 | 466,121.80 | -1.49 | 3.50 | -1.55 | 3.78 | 63.03 | 72.02 | -5.41 | 9.79 | 7.80 | -- | 0.0118 | 32.69 | -5.33 | 5.80 | -46.85 | -22.05 | -7.83 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 566.02m | 79.32m | 2.61bn | 1.08k | 34.71 | 2.11 | -- | 4.62 | 0.5367 | 0.5367 | 3.75 | 8.81 | 0.335 | 2.65 | 4.37 | 523,125.40 | 4.81 | 7.56 | 5.10 | 8.33 | 41.07 | 36.85 | 14.35 | 16.26 | 6.46 | 9.35 | 0.2334 | 21.03 | 20.63 | 17.68 | 107.51 | 1.76 | 14.94 | -27.21 |
| Jiangsu Cowin Biotech Co Ltd | 167.17m | -137.72m | 2.77bn | 833.00 | -- | 1.99 | -- | 16.59 | -1.24 | -1.24 | 1.51 | 12.36 | 0.1038 | 1.81 | 2.52 | 200,679.40 | -8.91 | 2.79 | -9.42 | 2.97 | 45.15 | 68.50 | -85.88 | 11.47 | 13.54 | -- | 0.0156 | 32.07 | -26.54 | 11.23 | -86.25 | -- | 34.36 | -- |
Data as of Feb 13 2026. Currency figures normalised to AVE Science & Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
10.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 477.39k | 3.45% |
| Essence Fund Co., Ltd.as of 30 Jun 2025 | 262.82k | 1.90% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 189.66k | 1.37% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 170.40k | 1.23% |
| Hui'an Fund Management Co. Ltd.as of 30 Jun 2025 | 93.97k | 0.68% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 60.63k | 0.44% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 49.18k | 0.36% |
| SWS MU Fund Management Co., Ltd.as of 30 Jun 2025 | 38.83k | 0.28% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 33.60k | 0.24% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2025 | 27.10k | 0.20% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
